Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection
- 30 April 2004
- journal article
- research article
- Published by Elsevier BV in Experimental Neurology
- Vol. 186 (2), 248-251
- https://doi.org/10.1016/j.expneurol.2003.12.006
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinasesAnnals of Neurology, 2003
- Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the ratJournal of Chromatography B, 2003
- Toward Wisdom From FailureStroke, 2002
- Minocycline markedly protects the neonatal brain against hypoxic‐ischemic injuryAnnals of Neurology, 2002
- Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's diseaseProceedings of the National Academy of Sciences of the United States of America, 2001
- Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neuronsNeuroscience Letters, 2001
- Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatumBrain Research, 2001
- Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in miceNature Medicine, 2000
- High-performance liquid chromatographic assay for minocycline in human plasma and parotid salivaJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Comparison of the Effectiveness of Tetracycline and Minocycline as Pleural Sclerosing Agents in RabbitsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1994